MedTrace Logo

Risk of Aspergillus Infection in Patients With Chronic Lung Disease

NCT06379568 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 209

Last updated 2024-04-23

No results posted yet for this study

Summary

Large doses of systemic corticosteroids ，severe lung tissue damage and longer COPD diagnosis may increase the risk of IPA in patients with chronic structural lung disease. By comparing the risk factors of aspergillus colonization group and aspergillus infection group, the main risk factors of aspergillus pneumonia were determined.

Conditions

  • Fungal Infection Lungs

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Lin Chen

    lead OTHER

Principal Investigators

  • Lin Chen, doctor · Sichuan Provincial People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2024-01-31
Completion
2024-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06379568 on ClinicalTrials.gov